Schedule 13G ownership disclosure

SYNAGEVA BIOPHARMA CORP

Security class unavailable · CUSIP: 87159A103

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000858744-16-000037
Form type
SC 13G/A
Filer
SMALLCAP WORLD FUND INC
CIK
CIK 858744
Filed
Feb 16, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub